Skip to main content
. 2020 Jul 10;12(7):2049. doi: 10.3390/nu12072049

Figure 3.

Figure 3

Plasma creatine kinase concentration (U/L; A), plasma interleukin 6 concentration (pg/mL; B), homeostatic model of assessment insulin resistance (HOMA-IR; C) and muscle soreness rating (mm; D). ** indicates significant main time effect from baseline (p ≤ 0.01); * indicates significant main time effect from baseline (p ≤ 0.05); # indicates significantly different from all other time points (p ≤ 0.01).